Reactivation of Hepatitis B After Ibalizumab Therapy for Multidrug-Resistant Human Immunodeficiency Virus

被引：2
作者：
Kaplan, Alyson [1 ]
DeHaan, Elliott [2 ]
Maltz, Charles [1 ]
机构：
[1] New York Presbyterian, Dept Med, Div Gastroenterol & Hepatol, Weill Cornell Sch Med, New York, NY 10065 USA
[2] New York Presbyterian, Dept Med, Div Infect Dis, Weill Cornell Sch Med, New York, NY USA
来源：
ACG CASE REPORTS JOURNAL | 2021年 / 8卷 / 05期
关键词：
MONOCLONAL-ANTIBODY; HIV-1;
D O I：
10.14309/crj.0000000000000594
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Despite the decreasing morbidity associated with the human immunodeficiency virus (HIV), a large percentage of persons with HIV have at least 1 drug resistance mutation. Ibalizumab, a recently approved drug, targets multidrug-resistant HIV. We present a case of reactivation of hepatitis B after initiation of ibalizumab therapy.
引用
收藏
页数：3
相关论文
共 50 条
  • [21] The Hepatitis B Virus Ribonuclease H Is Sensitive to Inhibitors of the Human Immunodeficiency Virus Ribonuclease H and Integrase Enzymes
    Tavis, John E.
    Cheng, Xiaohong
    Hu, Yuan
    Totten, Michael
    Cao, Feng
    Michailidis, Eleftherios
    Aurora, Rajeev
    Meyers, Marvin J.
    Jacobsen, E. Jon
    Parniak, Michael A.
    Sarafianos, Stefan G.
    PLOS PATHOGENS, 2013, 9 (01)
  • [22] Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA
    McCormick, M. K.
    Dockter, J.
    Linnen, J. M.
    Kolk, D.
    Wu, Y.
    Giachetti, C.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 (03) : 166 - 176
  • [23] A 12-YEAR-OLD BOY WITH MULTIDRUG-RESISTANT HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUCCESSFULLY TREATED WITH HAART INCLUDING RITONAVIR-BOOSTED TIPRANAVIR ORAL SOLUTION AND ENFUVIRTIDE
    Feiterna-Sperling, C.
    Walter, H.
    Wahn, V.
    Kleinkauf, N.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2009, 14 (01) : 44 - 46
  • [24] Differential effects of phorbol-13-monoesters on human immunodeficiency virus reactivation
    Marquez, Nieves
    Calzado, Marco A.
    Sanchez-Duffhues, Gonzalo
    Perez, Moises
    Minassi, Alberto
    Pagani, Alberto
    Appendino, Giovanni
    Diaz, Laura
    Angeles Munoz-Fernandez, Maria
    Munoz, Eduardo
    BIOCHEMICAL PHARMACOLOGY, 2008, 75 (06) : 1370 - 1380
  • [25] Multiplex real-time quantitative RT-PCR assay for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1
    Candotti, D
    Temple, J
    Owusu-Ofori, S
    Allain, JP
    JOURNAL OF VIROLOGICAL METHODS, 2004, 118 (01) : 39 - 47
  • [26] DECREASING THE RISK OF HUMAN-IMMUNODEFICIENCY-VIRUS OR HEPATITIS-B VIRUS-INFECTION DURING ENDOSCOPIC SURGERY
    WHELAN, JP
    FINLAYSON, B
    JOURNAL OF UROLOGY, 1991, 145 (04) : 807 - 809
  • [27] Acute Hepatitis due to Primary Human Immunodeficiency Virus Infection
    Elliott, Eric, I
    Smith, Daisy
    Lipscomb, Jonathan
    Banini, Bubu
    Meurer, Lindsay
    Vanderford, Thomas H.
    Johnson, Jeffrey A.
    Jain, Dhanpat
    Achhra, Amit
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (04):
  • [28] Intradermal Hepatitis B Vaccination in Non-responder People Living with Human Immunodeficiency Virus in Japan
    Yoshimura, Yukihiro
    Sasaki, Hiroaki
    Miyata, Nobuyuki
    Tachikawa, Natsuo
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2022, 75 (05) : 519 - 522
  • [29] Modern Human Immunodeficiency Virus Therapy: Progress and Prospects
    Flexner, Charles
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (01) : 61 - 70
  • [30] Clonal Expansion of Human Immunodeficiency Virus-Infected Cells and Human Immunodeficiency Virus Persistence During Antiretroviral Therapy
    Mullins, James I.
    Frenkel, Lisa M.
    JOURNAL OF INFECTIOUS DISEASES, 2017, 215 : S119 - S127
12345